CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C02204 | BRD-A91448670 | mandelic-acid | -- | -- | -- | Details |
| C02205 | BRD-A91452556 | estradiol-cypionate | ESR1 | Estrogen receptor agonist | -- | Details |
| C02206 | BRD-A91461229 | BRD-A91461229 | -- | -- | -- | Details |
| C02207 | BRD-A91477472 | dihydroptaeroxylin | -- | -- | -- | Details |
| C02208 | BRD-A91555231 | BRD-A91555231 | -- | -- | norepinephrine | Details |
| C02209 | BRD-A91658086 | FQI-1 | -- | -- | -- | Details |
| C02210 | BRD-A91699651 | chloroquine | -- | -- | -- | Details |
| C02211 | BRD-A91712064 | BRD-A91712064 | -- | -- | -- | Details |
| C02212 | BRD-A91785330 | BRD-A91785330 | -- | -- | -- | Details |
| C02213 | BRD-A91822151 | picrotin | GLRA2; GLRB; GLRA3 | GABA receptor antagonist | -- | Details |
| C02214 | BRD-A91823394 | BRD-A91823394 | -- | -- | -- | Details |
| C02215 | BRD-A91866971 | SQ-29548 | TBXA2R | Thromboxane receptor antagonist | -- | Details |
| C02216 | BRD-A91877226 | capecitabine | TYMS | DNA synthesis inhibitor; Thymidylate synthase inhibitor | -- | Details |
| C02217 | BRD-A91891312 | BRD-A91891312 | -- | -- | -- | Details |
| C02218 | BRD-A91931411 | BRD-A91931411 | -- | -- | -- | Details |
| C02219 | BRD-A91992993 | siguazodan | PDE3A | Phosphodiesterase inhibitor | -- | Details |
| C02220 | BRD-A92148199 | PD-149163 | -- | -- | -- | Details |
| C02221 | BRD-A92161634 | scopoline | -- | -- | -- | Details |
| C02222 | BRD-A92177080 | betamethasone-acetate | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C02223 | BRD-A92334183 | BRD-A92334183 | -- | -- | -- | Details |
| C02224 | BRD-A92357389 | BRD-A92357389 | -- | -- | -- | Details |
| C02225 | BRD-A92439610 | BRD-A92439610 | -- | -- | triamcinolone-acetonide | Details |
| C02226 | BRD-A92490200 | BRD-A92490200 | -- | -- | -- | Details |
| C02227 | BRD-A92537424 | danazol | ESR1; GNRHR | Estrogen receptor antagonist; Progesterone receptor agonist | -- | Details |
| C02228 | BRD-A92561457 | BRD-A92561457 | -- | -- | -- | Details |
| C02229 | BRD-A92585442 | RU-28318 | NR3C2 | Cytochrome P450 inhibitor | -- | Details |
| C02230 | BRD-A92630576 | trimebutine | OPRD1; OPRK1; OPRM1 | Opioid receptor agonist | -- | Details |
| C02231 | BRD-A92651262 | nalbuphine | OPRD1; OPRK1; OPRM1 | Opioid receptor agonist; Opioid receptor antagonist | -- | Details |
| C02232 | BRD-A92664907 | BRD-A92664907 | -- | -- | -- | Details |
| C02233 | BRD-A92670106 | tocainide | SCN5A | Sodium channel blocker | -- | Details |
| C02234 | BRD-A92729194 | BRD-A92729194 | -- | -- | -- | Details |
| C02235 | BRD-A92800748 | BRD-A92800748 | -- | -- | tie2-kinase-inhibitor | Details |
| C02236 | BRD-A92826379 | lupanine | INS | Sodium channel blocker | -- | Details |
| C02237 | BRD-A92933783 | SM-21 | PGRMC1 | Sigma receptor antagonist | -- | Details |
| C02238 | BRD-A93000692 | ciglitazone | PPARG | PPAR receptor agonist | -- | Details |
| C02239 | BRD-A93015352 | BRD-A93015352 | -- | -- | -- | Details |
| C02240 | BRD-A93048969 | BRD-A93048969 | CHRM1; CHRM2; CHRM3; CHRM4 | Acetylcholine receptor antagonist | -- | Details |
| C02241 | BRD-A93093700 | temazepam | GABRA1; GABRA2; GABRA3; GABRA4; GABRA5; GABRA6; GABRB1; GABRB2; GABRB3; GABRD; GABRE; GABRG1; GABRG2; GABRG3; GABRP; GABRQ | GABA receptor agonist | -- | Details |
| C02242 | BRD-A93206962 | L-755507 | ADRB3 | Adrenergic receptor agonist | -- | Details |
| C02243 | BRD-A93236127 | digitoxin | ATP1A1 | ATPase inhibitor | -- | Details |
| C02244 | BRD-A93255169 | thalidomide | CRBN; TNF | TNF production inhibitor | -- | Details |
| C02245 | BRD-A93269281 | clopidogrel | P2RY12 | Purinergic receptor antagonist | -- | Details |
| C02246 | BRD-A93291428 | oxymetholone | AR | Androgen receptor agonist | -- | Details |
| C02247 | BRD-A93353767 | isoconazole | -- | -- | -- | Details |
| C02248 | BRD-A93393712 | CVF-SUMO-14 | -- | -- | -- | Details |
| C02249 | BRD-A93424738 | dexamethasone-acetate | NR3C1 | Corticosteroid agonist; Cytochrome P450 inhibitor; Glucocorticoid receptor agonist | -- | Details |
| C02250 | BRD-A93426597 | BRD-A93426597 | -- | -- | -- | Details |
| C02251 | BRD-A93436351 | BRD-A93436351 | -- | -- | -- | Details |
| C02252 | BRD-A93477898 | PETCM | -- | -- | petcm | Details |
| C02253 | BRD-A93507363 | BRD-A93507363 | -- | -- | -- | Details |
| C02254 | BRD-A93659613 | GR-89696 | OPRK1 | Opioid receptor agonist | -- | Details |
| C02255 | BRD-A93683007 | mabuprofen | -- | -- | -- | Details |
| C02256 | BRD-A93739713 | atropine | CHRM1; CHRM2; CHRM3; CHRM4; CHRM5 | Acetylcholine receptor antagonist | -- | Details |
| C02257 | BRD-A93893742 | EMF-sumo1-2 | -- | -- | -- | Details |
| C02258 | BRD-A93942655 | BRD-A93942655 | -- | -- | -- | Details |
| C02259 | BRD-A93964801 | clinafloxacin | -- | -- | -- | Details |
| C02260 | BRD-A93975555 | BRD-A93975555 | -- | -- | -- | Details |
| C02261 | BRD-A94033181 | AZD-6765 | -- | -- | -- | Details |
| C02262 | BRD-A94046266 | BRD-A94046266 | -- | -- | -- | Details |
| C02263 | BRD-A94276798 | talinolol | ADRB1 | Adrenergic receptor antagonist | -- | Details |
| C02264 | BRD-A94297859 | BRD-A94297859 | XIAP | XIAP inhibitor | -- | Details |
| C02265 | BRD-A94366206 | BRD-A94366206 | -- | -- | -- | Details |
| C02266 | BRD-A94377914 | merck-ketone | -- | -- | -- | Details |
| C02267 | BRD-A94381689 | BRD-A94381689 | -- | -- | -- | Details |
| C02268 | BRD-A94413429 | NTNCB | NPY5R | Neuropeptide receptor antagonist | -- | Details |
| C02269 | BRD-A94420133 | BRD-A94420133 | -- | -- | -- | Details |
| C02270 | BRD-A94451536 | BRD-A94451536 | -- | -- | 2-fluoropalmitic-acid | Details |
| C02271 | BRD-A94465834 | BRD-A94465834 | -- | -- | -- | Details |
| C02272 | BRD-A94494639 | BRD-A94494639 | -- | -- | chlorpromazine | Details |
| C02273 | BRD-A94523291 | BRD-A94523291 | -- | -- | prednisolone-sodium-phosphate | Details |
| C02274 | BRD-A94543220 | bifonazole | -- | -- | -- | Details |
| C02275 | BRD-A94546435 | BRD-A94546435 | -- | -- | -- | Details |
| C02276 | BRD-A94567954 | BRD-A94567954 | -- | -- | -- | Details |
| C02277 | BRD-A94570195 | BRD-A94570195 | -- | -- | -- | Details |
| C02278 | BRD-A94624445 | bucladesine | PRKACA | CAMP stimulant; Adenosine receptor agonist | -- | Details |
| C02279 | BRD-A94659883 | BRD-A94659883 | -- | -- | -- | Details |
| C02280 | BRD-A94669766 | naringenin | CYP19A1; ESR2 | TRPV antagonist; Aromatase inhibitor | -- | Details |
| C02281 | BRD-A94675310 | BRD-A94675310 | -- | -- | -- | Details |
| C02282 | BRD-A94698726 | BRD-A94698726 | -- | -- | -- | Details |
| C02283 | BRD-A94702766 | ginkgolide-a | -- | -- | -- | Details |
| C02284 | BRD-A94709349 | metaxalone | -- | -- | -- | Details |
| C02285 | BRD-A94740628 | BRD-A94740628 | -- | -- | -- | Details |
| C02286 | BRD-A94756469 | digoxin | ATP1A1 | ATPase inhibitor | -- | Details |
| C02287 | BRD-A94793051 | gestrinone | ESR1; AR; PGR | Progesterone receptor antagonist | -- | Details |
| C02288 | BRD-A94796533 | zearalenone | -- | -- | -- | Details |
| C02289 | BRD-A94810754 | ionomycin | -- | -- | -- | Details |
| C02290 | BRD-A94885304 | BRD-A94885304 | -- | -- | -- | Details |
| C02291 | BRD-A94965935 | cicloprofen | -- | -- | -- | Details |
| C02292 | BRD-A94993966 | vildagliptin | DPP4 | Dipeptidyl peptidase inhibitor | -- | Details |
| C02293 | BRD-A95032015 | abacavir | -- | -- | -- | Details |
| C02294 | BRD-A95074085 | BRD-A95074085 | -- | -- | dibutyryl-cAMP-Na | Details |
| C02295 | BRD-A95096829 | PNU-96415E | -- | -- | -- | Details |
| C02296 | BRD-A95207036 | BRD-A95207036 | -- | -- | cyproterone-acetate | Details |
| C02297 | BRD-A95239561 | BRD-A95239561 | -- | -- | -- | Details |
| C02298 | BRD-A95442017 | BRD-A95442017 | -- | -- | -- | Details |
| C02299 | BRD-A95445494 | maackiain | -- | -- | -- | Details |
| C02300 | BRD-A95480808 | BRD-A95480808 | -- | -- | -- | Details |
| C02301 | BRD-A95489119 | BRD-A95489119 | -- | -- | -- | Details |
| C02302 | BRD-A95504714 | BRD-A95504714 | -- | -- | -- | Details |
| C02303 | BRD-A95513702 | BRD-A95513702 | -- | -- | androsta-1,4-dien-3,17-dione | Details |